[
  {
    "text": "\nVaccine operators must be adequately trained in OSHA's bloodborne pathogens standard (29 CFR 1910.1030) and receive additional training as needed. osha.gov/coronavirus This document does not have the force or effect of law and is in no way intended to operate as a mandate to the public. This document is intended only to provide clarity to the public.\n    ",
    "identifier": "spanish3512",
    "title": "Safety Tips for Keeping Workers Safe at COVID-19 Virus Vaccination Sites",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "id": "ConsejosdeSeguridadparaMantenerSegurosalosTrabajadoresenlosSitiosdeVacunacionContraelVirusCOVID-19#~#756925#~#www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "date-crawl": "2021-12-10 at 14:44:43",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "url-orig": "https://www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "source": "www.osha.gov",
      "date": "10/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Conseils de s\u00e9curit\u00e9 pour assurer la s\u00e9curit\u00e9 des travailleurs sur les sites de vaccination contre le virus COVID-19\n\nLes op\u00e9rateurs de vaccins doivent \u00eatre form\u00e9s de mani\u00e8re ad\u00e9quate \u00e0 la norme OSHA sur les pathog\u00e8nes transmissibles par le sang (29 CFR 1910.1030) et recevoir une formation suppl\u00e9mentaire si n\u00e9cessaire. osha.gov/coronavirus Ce document n'a pas force de loi et n'est en aucun cas destin\u00e9 \u00e0 fonctionner comme un mandat pour le public. Ce document a pour seul but de fournir des \u00e9claircissements au public.\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nthe health effects of cash transfer programs in low- and middle-income countries is particularly relevant in the current global economic crisis caused by COVID-19, which is likely to last, because these poverty-alleviating interventions could help the most impoverished populations, Rasella concludes.\n    ",
    "identifier": "spanish4330",
    "title": "Social programs that transfer cash can reduce maternal mortality",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "id": "Losprogramassocialesquetransfierendineroenefectivopuedendisminuirlamortalidadmaterna-News-ISGLOBAL#~#8700#~#www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "date-crawl": "2021-06-22 at 06:46:12",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "url-orig": "https://www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "source": "www.isglobal.org",
      "date": "22/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Les programmes sociaux qui transf\u00e8rent des fonds peuvent r\u00e9duire la mortalit\u00e9 maternelle\n\nLes effets sur la sant\u00e9 des programmes de transferts mon\u00e9taires dans les pays \u00e0 revenu faible et interm\u00e9diaire sont particuli\u00e8rement pertinents dans le contexte de la crise \u00e9conomique mondiale actuelle caus\u00e9e par COVID-19, qui risque de durer, car ces interventions visant \u00e0 att\u00e9nuer la pauvret\u00e9 pourraient aider les populations les plus d\u00e9munies, conclut Rasella.\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\non the immune system due to disease or treatment. If the person answered YES to question 5: if the person has been recently vaccinated, at least 7 days must have passed since then for vaccination against covid-19 to be relevant. To be completed by the vaccination clinic: Covid-19 vaccine name: Dose 1 \u274f Dose 2 \u274f Dose 3 \u274f Batch/lot number: Vaccine administered in: Right arm \u274f Left arm \u274f Other, if applicable\n    ",
    "identifier": "swedish1333",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#119078#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-10-13 at 21:51:29",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "13/10/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "D\u00e9claration de sant\u00e9 vaccination des adultes contre le COVID-19\n\nsur le syst\u00e8me immunitaire en raison d'une maladie ou d'un traitement. Si la personne a r\u00e9pondu OUI \u00e0 la question 5 : si la personne a \u00e9t\u00e9 r\u00e9cemment vaccin\u00e9e, au moins 7 jours doivent s'\u00eatre \u00e9coul\u00e9s depuis pour que la vaccination contre le covid-19 soit pertinente. A remplir par le centre de vaccination : Nom du vaccin Covid-19 : Dose 1 \u274f Dose 2 \u274f Dose 3 \u274f Num\u00e9ro de lot : Vaccin administr\u00e9 dans : Bras droit \u274f Bras gauche \u274f Autre, le cas \u00e9ch\u00e9ant\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nChronic liver or kidney failure.\n' Conditions involving immune system impairment due to disease or treatment.\nIf the person answered YES to question 5: if the person has been recently vaccinated, at least 7 days must have passed since then for vaccination against covid-19 to be relevant.\nThe following is completed by the vaccination clinic: Covid-19 vaccine name: Dose 1 ' \" Dose 2 ' \" Batch/lot number: The vaccine has been administered in: Right arm ' \" Left arm ' \" Any other location for administration: Any comments: Health care provider: Reception/unit: Name of vaccinator: Signature: PUBLIC HEALTH AUTHORITY,\n2021\n    ",
    "identifier": "swedish3091",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#137945#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-07-01 at 19:01:11",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "01/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "D\u00e9claration de sant\u00e9 vaccination des adultes contre le COVID-19\n\n' Insuffisance h\u00e9patique ou r\u00e9nale chronique.\n' Conditions impliquant une d\u00e9ficience du syst\u00e8me immunitaire due \u00e0 une maladie ou \u00e0 un traitement.\nSi la personne a r\u00e9pondu OUI \u00e0 la question 5 : si la personne a \u00e9t\u00e9 vaccin\u00e9e r\u00e9cemment, au moins 7 jours doivent s'\u00eatre \u00e9coul\u00e9s depuis pour que la vaccination contre le covid-19 soit pertinente.\nLe tableau suivant est rempli par le centre de vaccination : Nom du vaccin Covid-19 : Dose 1 ' \" Dose 2 ' \" Num\u00e9ro de lot : Le vaccin a \u00e9t\u00e9 administr\u00e9 dans : Bras droit ' \" Bras gauche ' \" Tout autre endroit d'administration : Tout commentaire : Prestataire de soins de sant\u00e9 : R\u00e9ception/unit\u00e9 : Nom du vaccinateur : Signature : AUTORIT\u00c9 DE SANT\u00c9 PUBLIQUE,\n2021\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nEMA published new safety updates for Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna and Vaxzevria\nEMA updated the guidance on preparing risk management plans for COVID-19 vaccines\n    ",
    "identifier": "english2",
    "title": "COVID-19: latest updates | European Medicines Agency",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "id": "COVID-19:latestupdatesEuropeanMedicinesAgency#~#310304#~#www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "date-crawl": "2021-06-28 at 11:36:01",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "url-orig": "https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "source": "www.ema.europa.eu",
      "date": "28/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "COVID-19 : derni\u00e8res mises \u00e0 jour | Agence europ\u00e9enne des m\u00e9dicaments\n\nL'EMA a publi\u00e9 de nouvelles mises \u00e0 jour de s\u00e9curit\u00e9 pour Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna et Vaxzevria.\nL'EMA a mis \u00e0 jour le guide sur la pr\u00e9paration des plans de gestion des risques pour les vaccins COVID-19\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\n142 new cases of COVID-19 reported\n9,816 new tests for COVID-19 that reported results\n    ",
    "identifier": "english5",
    "title": "Coronavirus (COVID-19): daily data for Scotland - gov.scot",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "id": "CoronavirusCOVID-19:dailydataforScotland-gov.scot#~#48749#~#www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "date-crawl": "2021-04-26 at 20:22:35",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "url-orig": "https://www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "source": "www.gov.scot",
      "date": "26/04/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Coronavirus (COVID-19) : donn\u00e9es quotidiennes pour l'Ecosse - gov.scot\n\n142 nouveaux cas de COVID-19 signal\u00e9s\n9 816 nouveaux tests pour le COVID-19 dont les r\u00e9sultats ont \u00e9t\u00e9 rapport\u00e9s\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nThe year 2020 will go down in history as the first year of the outbreak of the SARS-CoV-2 virus (coronavirus). The Dutch government took measures to stop the spread of the coronavirus. It seems that other infectious diseases were also less prevalent as a result. For example, there was\ngone by infectious diseases. This is expressed in disability-adjusted life years (DALYs); also called the burden of disease. In 2020, the most healthy life years were lost in the Netherlands to COVID-19 (169,400 DALYs), legionella (6,300 DALYs) and severe pneumococcal disease (6,200 DALYs. This top three is different than previous years because of COVID-19. In 2019, they were: severe pneumococcal disease\n    ",
    "identifier": "dutch569",
    "title": "State of infectious diseases in the Netherlands, 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "id": "StaatvaninfectieziekteninNederland,2020#~#7764#~#www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "date-crawl": "2021-12-13 at 19:10:10",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "source": "www.rivm.nl",
      "date": "13/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Situation des maladies infectieuses aux Pays-Bas, 2020\n\nL'ann\u00e9e 2020 restera dans l'histoire comme la premi\u00e8re ann\u00e9e de l'\u00e9pid\u00e9mie du virus SRAS-CoV-2 (coronavirus). Le gouvernement n\u00e9erlandais a pris des mesures pour stopper la propagation du coronavirus. Il semble que d'autres maladies infectieuses aient \u00e9t\u00e9 moins r\u00e9pandues en cons\u00e9quence. Par exemple, il y a eu\ndisparu par les maladies infectieuses. Ce chiffre est exprim\u00e9 en ann\u00e9es de vie corrig\u00e9es de l'incapacit\u00e9 (AVCI) ; on l'appelle aussi la charge de morbidit\u00e9. En 2020, le plus grand nombre d'ann\u00e9es de vie en bonne sant\u00e9 ont \u00e9t\u00e9 perdues aux Pays-Bas \u00e0 cause du COVID-19 (169 400 AVCI), de la l\u00e9gionellose (6 300 AVCI) et des infections graves \u00e0 pneumocoques (6 200 AVCI). Ce trio de t\u00eate est diff\u00e9rent des ann\u00e9es pr\u00e9c\u00e9dentes en raison de COVID-19. En 2019, il s'agissait de : maladies pneumococciques s\u00e9v\u00e8res\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nis vaccinated. This is especially true for whooping cough, mumps, meningococcal disease, pneumococcal disease and measles. This is most likely due to the measures introduced because of the SARS-CoV-2 coronavirus outbreak. Examples include hand washing, keeping your distance, the (temporary) closure of schools and daycare centers, the smaller number of people at gatherings, and the maximum number to be received\nThe coronavirus outbreak also affected the way RVP was implemented in 2020. Group vaccinations (for children aged 9 and older) were first postponed or converted to individual appointments. From July 1\n    ",
    "identifier": "dutch1133",
    "title": "Vaccination rate and annual report National Vaccination Program Netherlands 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "id": "VaccinatiegraadenjaarverslagRijksvaccinatieprogrammaNederland2020RIVM#~#8516#~#www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "date-crawl": "2021-07-05 at 15:57:20",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "source": "www.rivm.nl",
      "date": "05/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Taux de vaccination et rapport annuel Programme national de vaccination Pays-Bas 2020\n\nest vaccin\u00e9. Cela est particuli\u00e8rement vrai pour la coqueluche, les oreillons, les m\u00e9ningocoques, les pneumocoques et la rougeole. Cela est tr\u00e8s probablement d\u00fb aux mesures introduites en raison de l'\u00e9pid\u00e9mie de coronavirus SRAS-CoV-2. Citons par exemple le lavage des mains, le maintien de la distance, la fermeture (temporaire) des \u00e9coles et des cr\u00e8ches, la r\u00e9duction du nombre de personnes lors des rassemblements et le nombre maximal de personnes \u00e0 accueillir...\nL'\u00e9pid\u00e9mie de coronavirus a \u00e9galement eu une incidence sur la mani\u00e8re dont le PVR a \u00e9t\u00e9 mis en \u0153uvre en 2020. Les vaccinations collectives (pour les enfants \u00e2g\u00e9s de 9 ans et plus) ont d'abord \u00e9t\u00e9 report\u00e9es ou converties en rendez-vous individuels. \u00c0 partir du 1er juillet\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nCovid-19: resources for the workplace\n Provides an overview of what will continue to be relevant in the future. EU-OSHA Acting Director William Cockburn provides an overview of emerging risks, and other colleagues highlight the continuing pandemic and offer advice on returning to\n    ",
    "identifier": "danish6948",
    "title": "Highlights | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "id": "HojdepunkterSafetyandhealthatworkEU-OSHA#~#124011#~#osha.europa.eu/da/highlights",
      "date-crawl": "2021-12-14 at 07:14:23",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "url-orig": "https://osha.europa.eu/da/highlights",
      "source": "osha.europa.eu",
      "date": "14/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Points forts | S\u00e9curit\u00e9 et sant\u00e9 au travail EU-OSHA\n\nCovid-19 : ressources pour le lieu de travail\n Fournit un aper\u00e7u de ce qui restera pertinent \u00e0 l'avenir. Le directeur par int\u00e9rim de l'EU-OSHA, William Cockburn, donne un aper\u00e7u des risques \u00e9mergents, tandis que d'autres coll\u00e8gues soulignent la persistance de la pand\u00e9mie et offrent des conseils sur le retour au\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nWith the end of the COVID-19 pandemic, it looks like working from home will continue to be used. But what can we learn from the companies that have been using teleworking since before the pandemic about how to ensure\n    ",
    "identifier": "czech5265",
    "title": "Key messages | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#122694#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-16 at 06:43:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "16/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Messages cl\u00e9s | S\u00e9curit\u00e9 et sant\u00e9 au travail EU-OSHA\n\nAvec la fin de la pand\u00e9mie de COVID-19, il semble que le travail \u00e0 domicile va continuer \u00e0 \u00eatre utilis\u00e9. Mais que peuvent nous apprendre les entreprises qui utilisent le t\u00e9l\u00e9travail depuis avant la pand\u00e9mie sur la fa\u00e7on de garantir que les employ\u00e9s sont bien form\u00e9s et qu'ils ont les moyens de le faire.\n    "
      }
    ],
    "sentences": []
  },
  {
    "text": "\nCOVID-19, telework and occupational health and safety: what lessons have we learned?\nIn light of the huge increase in teleworking caused by the COVID-19 pandemic, with many employees continuing to work from home, the new report looks at the associated health and safety risks. It includes in-depth interviews with workers\n    ",
    "identifier": "czech5395",
    "title": "Key messages | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#123448#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-28 at 06:59:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "28/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "Messages cl\u00e9s | S\u00e9curit\u00e9 et sant\u00e9 au travail EU-OSHA\n\nCOVID-19, t\u00e9l\u00e9travail et sant\u00e9 et s\u00e9curit\u00e9 au travail : quelles le\u00e7ons avons-nous tir\u00e9es ?\n\u00c0 la lumi\u00e8re de l'augmentation consid\u00e9rable du t\u00e9l\u00e9travail caus\u00e9e par la pand\u00e9mie COVID-19, avec de nombreux employ\u00e9s continuant \u00e0 travailler \u00e0 domicile, le nouveau rapport examine les risques associ\u00e9s en mati\u00e8re de sant\u00e9 et de s\u00e9curit\u00e9. Il comprend des entretiens approfondis avec des travailleurs\n    "
      }
    ],
    "sentences": []
  }
]
